Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
Autor: | Mahon, François-Xavier, Réa, Delphine, Guilhot, Joëlle, Guilhot, François, Huguet, Françoise, Nicolini, Franck, Legros, Laurence, Charbonnier, Aude, Guerci, Agnès, Varet, Bruno, Etienne, Gabriel, Reiffers, Josy, Rousselot, Philippe |
---|---|
Zdroj: | In Lancet Oncology 2010 11(11):1029-1035 |
Databáze: | ScienceDirect |
Externí odkaz: |